ELIMINATION KINETICS OF SULFADIAZINE IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION

被引：19

作者：

OHNHAUS, EE ^{[1
]}

SPRING, P ^{[1
]}

机构：

[1] UNIV BASEL,KANTONSSPITAL,CLIN 2,DEPT MED,4004 BASEL,SWITZERLAND

来源：

JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS | 1975年 / 3卷 / 03期

关键词：

D O I：

10.1007/BF01067906

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：171 / 179

页数：9

共 20 条

[1] SERUM CREATININE DETERMINATION WITHOUT PROTEIN PRECIPITATION [J].

BARTELS, H ;

BOHMER, M ;

HEIERLI, C .

CLINICA CHIMICA ACTA, 1972, 37 (NMAR) :193-&

[2]

Bratton AC, 1939, J BIOL CHEM, V128, P537

[3] THE PATHOLOGIC PHYSIOLOGY OF CHRONIC BRIGHTS DISEASE - AN EXPOSITION OF THE INTACT NEPHRON HYPOTHESIS [J].

BRICKER, NS ;

MORRIN, PAF ;

KIME, SW .

AMERICAN JOURNAL OF MEDICINE, 1960, 28 (01) :77-98

[4]

BUENGER P, 1961, ARZNEIMITTELFORSCH, V11, P247

[5]

DETTLI L, 1970, POSTGRAD MED J, V46, P32

[6] INDIVIDUALIZATION OF DRUG DOSAGE IN PATIENTS WITH RENAL-DISEASE [J].

DETTLI, L .

MEDICAL CLINICS OF NORTH AMERICA, 1974, 58 (05) :977-985

[7] UBER DIE EIWEISSBINDUNG DER SULFANILAMIDE IN VITRO UND IN VIVO [J].

DETTLI, L ;

SPRING, P ;

BAUR, M .

CHEMOTHERAPY, 1963, 6 (45) :196-&

[8]

DETTLI L, 1971, ACTA PHARMACOL TOX, V29, P211

[9]

DETTLI L, 1973, BIOLOGICAL EFFECTS D

[10]

DETTLI L, 1964, 3 INT C CHEM, P641

← 1 2 →